SCHEMBL7157134

SCHEMBL7157134

CCN([CH]CN(C)C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11109235 0.84
SCHEMBL4646482 0.75
SCHEMBL93377 0.69
SCHEMBL5695297 0.66 KCNH2 (0.36)
SCHEMBL19458947 0.65
SCHEMBL2745893 0.65
SCHEMBL181617 0.65
SCHEMBL2118229 0.65
SCHEMBL386205 0.62
N,N-Dimethylethanaminium SCHEMBL352062 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611348-B2 Process of producing polyolefins using metallocene polymerization catalysts and copolymers therefrom EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-04-04 US claimed
US-6548514-B1 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders ASTRAZENECA AB (SE) 2003-04-15 US disclosed